| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Delirium | 40 | 2025 | 1696 | 3.400 |
Why?
|
| Magnetic Resonance Imaging, Cine | 13 | 2024 | 1092 | 1.150 |
Why?
|
| Chronic Periodontitis | 3 | 2014 | 104 | 0.850 |
Why?
|
| Postoperative Complications | 27 | 2025 | 15889 | 0.790 |
Why?
|
| Blood Proteins | 4 | 2024 | 1191 | 0.720 |
Why?
|
| Thiamine | 5 | 2024 | 160 | 0.700 |
Why?
|
| Myocardium | 16 | 2024 | 4790 | 0.700 |
Why?
|
| Leukoencephalopathy, Progressive Multifocal | 7 | 2015 | 133 | 0.690 |
Why?
|
| Magnetic Resonance Imaging | 40 | 2024 | 36854 | 0.680 |
Why?
|
| Mass Screening | 4 | 2021 | 5457 | 0.670 |
Why?
|
| Defibrillators, Implantable | 4 | 2024 | 1498 | 0.670 |
Why?
|
| Aged | 148 | 2025 | 171786 | 0.640 |
Why?
|
| Cardiomyopathies | 5 | 2024 | 2057 | 0.610 |
Why?
|
| Shock, Septic | 7 | 2023 | 774 | 0.600 |
Why?
|
| Multiple Sclerosis | 3 | 2023 | 3250 | 0.600 |
Why?
|
| Authorship | 4 | 2018 | 289 | 0.590 |
Why?
|
| Proteomics | 12 | 2025 | 3914 | 0.590 |
Why?
|
| Primary Prevention | 2 | 2024 | 1187 | 0.590 |
Why?
|
| Female | 208 | 2025 | 397515 | 0.570 |
Why?
|
| Reminder Systems | 2 | 2018 | 388 | 0.570 |
Why?
|
| Contrast Media | 16 | 2024 | 5334 | 0.560 |
Why?
|
| Aged, 80 and over | 75 | 2025 | 59739 | 0.550 |
Why?
|
| Gadolinium | 7 | 2024 | 965 | 0.540 |
Why?
|
| Predictive Value of Tests | 34 | 2025 | 15471 | 0.530 |
Why?
|
| Breast Neoplasms | 13 | 2024 | 21188 | 0.530 |
Why?
|
| Gingival Crevicular Fluid | 2 | 2014 | 96 | 0.520 |
Why?
|
| Humans | 283 | 2025 | 768970 | 0.520 |
Why?
|
| Male | 191 | 2025 | 365203 | 0.520 |
Why?
|
| Image Interpretation, Computer-Assisted | 12 | 2022 | 3411 | 0.510 |
Why?
|
| Subthalamic Nucleus | 1 | 2018 | 203 | 0.500 |
Why?
|
| JC Virus | 6 | 2015 | 87 | 0.490 |
Why?
|
| Middle Aged | 130 | 2025 | 223737 | 0.490 |
Why?
|
| Furcation Defects | 1 | 2014 | 37 | 0.480 |
Why?
|
| Patient Care Planning | 2 | 2017 | 904 | 0.470 |
Why?
|
| Cardiomyopathy, Dilated | 4 | 2024 | 843 | 0.470 |
Why?
|
| Periodontal Pocket | 1 | 2014 | 174 | 0.470 |
Why?
|
| Thiamine Deficiency | 2 | 2016 | 48 | 0.460 |
Why?
|
| Molar | 1 | 2014 | 155 | 0.450 |
Why?
|
| Tooth Root | 1 | 2014 | 162 | 0.450 |
Why?
|
| Hospitalization | 13 | 2022 | 10847 | 0.450 |
Why?
|
| C-Reactive Protein | 7 | 2024 | 3859 | 0.450 |
Why?
|
| Electronic Health Records | 8 | 2024 | 4879 | 0.450 |
Why?
|
| Insulin | 4 | 2023 | 6610 | 0.440 |
Why?
|
| Arrhythmias, Cardiac | 7 | 2024 | 2258 | 0.440 |
Why?
|
| Prospective Studies | 56 | 2025 | 54962 | 0.430 |
Why?
|
| Cardiomyopathy, Hypertrophic | 4 | 2024 | 1335 | 0.430 |
Why?
|
| Patient Discharge | 7 | 2024 | 3491 | 0.410 |
Why?
|
| Organometallic Compounds | 4 | 2019 | 648 | 0.410 |
Why?
|
| Periodontal Attachment Loss | 1 | 2012 | 152 | 0.400 |
Why?
|
| Patient Participation | 4 | 2024 | 1448 | 0.400 |
Why?
|
| Intracranial Thrombosis | 2 | 2023 | 108 | 0.400 |
Why?
|
| Image Enhancement | 13 | 2019 | 2898 | 0.390 |
Why?
|
| Adult | 114 | 2024 | 223851 | 0.390 |
Why?
|
| Maxilla | 1 | 2014 | 489 | 0.380 |
Why?
|
| Sepsis | 10 | 2011 | 2610 | 0.380 |
Why?
|
| Models, Statistical | 7 | 2016 | 5110 | 0.380 |
Why?
|
| Publishing | 4 | 2018 | 837 | 0.370 |
Why?
|
| Heart | 10 | 2022 | 4447 | 0.370 |
Why?
|
| Geriatric Assessment | 6 | 2023 | 1422 | 0.370 |
Why?
|
| Orthopedic Procedures | 5 | 2023 | 1280 | 0.370 |
Why?
|
| Endometriosis | 3 | 2024 | 874 | 0.360 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2012 | 505 | 0.360 |
Why?
|
| Multiple Organ Failure | 4 | 2020 | 387 | 0.340 |
Why?
|
| Learning Curve | 1 | 2012 | 232 | 0.340 |
Why?
|
| Risk Factors | 47 | 2025 | 74976 | 0.340 |
Why?
|
| Risk Assessment | 23 | 2025 | 24333 | 0.340 |
Why?
|
| Deep Brain Stimulation | 1 | 2018 | 851 | 0.340 |
Why?
|
| Vocabulary, Controlled | 3 | 2007 | 170 | 0.340 |
Why?
|
| Confusion | 4 | 2023 | 278 | 0.330 |
Why?
|
| Physicians | 4 | 2024 | 4607 | 0.330 |
Why?
|
| Magnetic Resonance Angiography | 6 | 2011 | 1434 | 0.330 |
Why?
|
| Women's Health | 5 | 2024 | 2081 | 0.320 |
Why?
|
| Acidosis, Lactic | 1 | 2010 | 145 | 0.310 |
Why?
|
| Mammography | 6 | 2024 | 2434 | 0.310 |
Why?
|
| Sample Size | 1 | 2012 | 848 | 0.310 |
Why?
|
| General Practice | 3 | 2020 | 101 | 0.310 |
Why?
|
| Problem-Based Learning | 1 | 2012 | 360 | 0.300 |
Why?
|
| Analgesics, Opioid | 5 | 2024 | 3838 | 0.300 |
Why?
|
| Diabetes Mellitus, Type 2 | 5 | 2023 | 12253 | 0.290 |
Why?
|
| Cytokines | 3 | 2019 | 7453 | 0.290 |
Why?
|
| Case-Control Studies | 19 | 2024 | 22296 | 0.290 |
Why?
|
| Hospitalists | 2 | 2022 | 298 | 0.290 |
Why?
|
| Occupational Therapy | 1 | 2009 | 141 | 0.290 |
Why?
|
| Ventricular Function, Left | 10 | 2024 | 3941 | 0.290 |
Why?
|
| Postmenopause | 1 | 2016 | 2519 | 0.280 |
Why?
|
| Insurance, Life | 1 | 2007 | 14 | 0.280 |
Why?
|
| Medicare | 15 | 2024 | 6888 | 0.280 |
Why?
|
| Radiology | 4 | 2018 | 2104 | 0.280 |
Why?
|
| Reproducibility of Results | 26 | 2023 | 20245 | 0.280 |
Why?
|
| Biomedical Research | 5 | 2018 | 3463 | 0.280 |
Why?
|
| Insurance, Disability | 1 | 2007 | 26 | 0.280 |
Why?
|
| Primary Health Care | 3 | 2019 | 4748 | 0.270 |
Why?
|
| Patients | 3 | 2023 | 908 | 0.270 |
Why?
|
| Periodicals as Topic | 3 | 2013 | 1470 | 0.270 |
Why?
|
| Decision Making | 4 | 2024 | 3953 | 0.270 |
Why?
|
| Logistic Models | 17 | 2024 | 13318 | 0.260 |
Why?
|
| Venous Thrombosis | 3 | 2023 | 1321 | 0.260 |
Why?
|
| Cardiovascular Diseases | 6 | 2024 | 15661 | 0.260 |
Why?
|
| Administration, Intranasal | 3 | 2022 | 485 | 0.260 |
Why?
|
| Health Education | 3 | 2007 | 1059 | 0.250 |
Why?
|
| Patient Access to Records | 4 | 2016 | 120 | 0.240 |
Why?
|
| Meglumine | 2 | 2019 | 144 | 0.240 |
Why?
|
| Activities of Daily Living | 5 | 2020 | 2434 | 0.240 |
Why?
|
| Doxorubicin | 2 | 2024 | 2234 | 0.240 |
Why?
|
| Cause of Death | 8 | 2024 | 3721 | 0.240 |
Why?
|
| Disabled Persons | 6 | 2013 | 1210 | 0.240 |
Why?
|
| Severity of Illness Index | 13 | 2023 | 15951 | 0.240 |
Why?
|
| Hypertension | 6 | 2024 | 8617 | 0.240 |
Why?
|
| Cicatrix | 4 | 2023 | 799 | 0.230 |
Why?
|
| Pelvic Pain | 2 | 2024 | 300 | 0.230 |
Why?
|
| Retrospective Studies | 41 | 2024 | 81903 | 0.230 |
Why?
|
| Parkinson Disease | 1 | 2018 | 2895 | 0.230 |
Why?
|
| Imaging, Three-Dimensional | 9 | 2018 | 4076 | 0.230 |
Why?
|
| Neuropsychological Tests | 7 | 2020 | 7148 | 0.230 |
Why?
|
| Early Detection of Cancer | 2 | 2015 | 3238 | 0.230 |
Why?
|
| Alzheimer Disease | 4 | 2024 | 8760 | 0.220 |
Why?
|
| Health Personnel | 2 | 2017 | 3383 | 0.220 |
Why?
|
| Ozone | 7 | 2005 | 496 | 0.220 |
Why?
|
| Dementia | 4 | 2023 | 2741 | 0.220 |
Why?
|
| Patient Preference | 2 | 2024 | 947 | 0.220 |
Why?
|
| Sensitivity and Specificity | 21 | 2023 | 14752 | 0.220 |
Why?
|
| Incidence | 16 | 2024 | 21547 | 0.210 |
Why?
|
| Algorithms | 15 | 2016 | 14201 | 0.210 |
Why?
|
| Respiratory-Gated Imaging Techniques | 3 | 2012 | 75 | 0.210 |
Why?
|
| Immune Reconstitution Inflammatory Syndrome | 2 | 2013 | 61 | 0.210 |
Why?
|
| Coronary Vessels | 5 | 2012 | 3124 | 0.210 |
Why?
|
| Nursing Assessment | 2 | 2021 | 107 | 0.200 |
Why?
|
| Physicians, Primary Care | 3 | 2015 | 625 | 0.200 |
Why?
|
| Disability Evaluation | 4 | 2013 | 1839 | 0.200 |
Why?
|
| Research Design | 2 | 2020 | 6214 | 0.200 |
Why?
|
| Reflex | 1 | 2024 | 375 | 0.200 |
Why?
|
| Prognosis | 14 | 2024 | 30046 | 0.200 |
Why?
|
| Nursing Diagnosis | 1 | 2021 | 16 | 0.200 |
Why?
|
| United States | 29 | 2024 | 73186 | 0.200 |
Why?
|
| Heart Atria | 2 | 2018 | 1361 | 0.200 |
Why?
|
| Mastectomy | 5 | 2013 | 1850 | 0.200 |
Why?
|
| Swine, Miniature | 1 | 2024 | 965 | 0.190 |
Why?
|
| Indocyanine Green | 4 | 2013 | 239 | 0.190 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2024 | 2336 | 0.190 |
Why?
|
| Pattern Recognition, Automated | 4 | 2012 | 998 | 0.190 |
Why?
|
| Heart Failure | 4 | 2022 | 11879 | 0.190 |
Why?
|
| Decision Support Techniques | 3 | 2024 | 2008 | 0.190 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 2 | 2021 | 1106 | 0.190 |
Why?
|
| Healthcare Disparities | 4 | 2024 | 3421 | 0.190 |
Why?
|
| Employment | 2 | 2007 | 1114 | 0.190 |
Why?
|
| Air Pollutants, Occupational | 3 | 2011 | 406 | 0.180 |
Why?
|
| Heart Arrest | 4 | 2019 | 1515 | 0.180 |
Why?
|
| Aortic Valve Stenosis | 2 | 2024 | 2034 | 0.180 |
Why?
|
| Hydrocarbons | 3 | 2006 | 105 | 0.180 |
Why?
|
| Diabetic Ketoacidosis | 1 | 2024 | 257 | 0.180 |
Why?
|
| Endomyocardial Fibrosis | 1 | 2020 | 41 | 0.180 |
Why?
|
| Hypotension, Orthostatic | 1 | 2023 | 258 | 0.170 |
Why?
|
| Atrial Function, Left | 2 | 2018 | 188 | 0.170 |
Why?
|
| Hospital Mortality | 10 | 2017 | 5369 | 0.170 |
Why?
|
| Double-Blind Method | 8 | 2024 | 12467 | 0.170 |
Why?
|
| Breast | 2 | 2023 | 1976 | 0.170 |
Why?
|
| Fluorometry | 2 | 2010 | 99 | 0.170 |
Why?
|
| Hypoglycemic Agents | 3 | 2022 | 3110 | 0.170 |
Why?
|
| Colonic Polyps | 3 | 2010 | 557 | 0.170 |
Why?
|
| Respiratory Mechanics | 3 | 2012 | 722 | 0.170 |
Why?
|
| Cohort Studies | 26 | 2024 | 41808 | 0.170 |
Why?
|
| Young Adult | 23 | 2024 | 60131 | 0.170 |
Why?
|
| Metabolomics | 3 | 2024 | 1675 | 0.170 |
Why?
|
| Health Plan Implementation | 2 | 2021 | 338 | 0.170 |
Why?
|
| Longitudinal Studies | 11 | 2024 | 14794 | 0.170 |
Why?
|
| HIV Infections | 6 | 2024 | 17591 | 0.170 |
Why?
|
| Hyperglycemia | 3 | 2024 | 1389 | 0.160 |
Why?
|
| Stroke Volume | 8 | 2024 | 5622 | 0.160 |
Why?
|
| Colectomy | 1 | 2024 | 699 | 0.160 |
Why?
|
| Disease Progression | 8 | 2024 | 13674 | 0.160 |
Why?
|
| Diabetes Mellitus | 5 | 2024 | 5892 | 0.160 |
Why?
|
| Polyomavirus Infections | 2 | 2011 | 192 | 0.160 |
Why?
|
| Histamine H2 Antagonists | 2 | 2011 | 169 | 0.160 |
Why?
|
| Inflammation | 5 | 2024 | 10868 | 0.160 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 6 | 2024 | 3813 | 0.160 |
Why?
|
| Manganese | 2 | 2011 | 394 | 0.150 |
Why?
|
| Nursing Staff, Hospital | 2 | 2021 | 350 | 0.150 |
Why?
|
| Proteome | 4 | 2022 | 1891 | 0.150 |
Why?
|
| Health Literacy | 2 | 2022 | 467 | 0.150 |
Why?
|
| Feasibility Studies | 5 | 2024 | 5323 | 0.150 |
Why?
|
| Liver Neoplasms | 2 | 2024 | 4363 | 0.150 |
Why?
|
| Boston | 13 | 2022 | 9377 | 0.150 |
Why?
|
| Diagnostic Techniques, Cardiovascular | 1 | 2019 | 153 | 0.150 |
Why?
|
| Blood Flow Velocity | 2 | 2013 | 1376 | 0.150 |
Why?
|
| Interleukin-6 | 3 | 2024 | 3232 | 0.150 |
Why?
|
| Blood-Brain Barrier | 2 | 2023 | 1036 | 0.150 |
Why?
|
| Neurofilament Proteins | 1 | 2020 | 337 | 0.150 |
Why?
|
| Heart Rate | 7 | 2022 | 4217 | 0.150 |
Why?
|
| Anti-Obesity Agents | 1 | 2021 | 240 | 0.150 |
Why?
|
| Health Facilities | 2 | 2023 | 577 | 0.150 |
Why?
|
| Geriatric Nursing | 1 | 2018 | 39 | 0.150 |
Why?
|
| Patient Education as Topic | 4 | 2016 | 2339 | 0.150 |
Why?
|
| Language | 3 | 2023 | 1559 | 0.150 |
Why?
|
| Follow-Up Studies | 12 | 2024 | 39394 | 0.150 |
Why?
|
| Communication | 5 | 2022 | 3908 | 0.150 |
Why?
|
| Pilot Projects | 14 | 2024 | 8748 | 0.150 |
Why?
|
| Epistasis, Genetic | 1 | 2020 | 353 | 0.140 |
Why?
|
| Physician-Patient Relations | 6 | 2024 | 3269 | 0.140 |
Why?
|
| Expert Systems | 1 | 1997 | 79 | 0.140 |
Why?
|
| Blood Pressure | 5 | 2024 | 8544 | 0.140 |
Why?
|
| Psychometrics | 3 | 2016 | 3066 | 0.140 |
Why?
|
| Hypotension | 1 | 2023 | 888 | 0.140 |
Why?
|
| Religion | 1 | 2021 | 376 | 0.140 |
Why?
|
| Pulmonary Artery | 2 | 2018 | 1945 | 0.140 |
Why?
|
| Nursing Homes | 2 | 2019 | 1084 | 0.140 |
Why?
|
| Ascorbic Acid | 1 | 2020 | 658 | 0.140 |
Why?
|
| Accidental Falls | 2 | 2023 | 1080 | 0.140 |
Why?
|
| Comorbidity | 15 | 2019 | 10592 | 0.140 |
Why?
|
| Opioid-Related Disorders | 2 | 2023 | 2188 | 0.140 |
Why?
|
| Emergency Service, Hospital | 10 | 2014 | 7957 | 0.140 |
Why?
|
| Phantoms, Imaging | 4 | 2019 | 2533 | 0.130 |
Why?
|
| Focus Groups | 3 | 2022 | 1462 | 0.130 |
Why?
|
| Cross Infection | 3 | 2020 | 1425 | 0.130 |
Why?
|
| Catechol O-Methyltransferase | 1 | 2018 | 251 | 0.130 |
Why?
|
| Coloring Agents | 4 | 2013 | 564 | 0.130 |
Why?
|
| Extracellular Matrix | 1 | 2024 | 1739 | 0.130 |
Why?
|
| Internet | 6 | 2016 | 3112 | 0.130 |
Why?
|
| Neural Stem Cells | 1 | 2023 | 895 | 0.130 |
Why?
|
| Time Factors | 18 | 2024 | 40261 | 0.130 |
Why?
|
| Obesity | 6 | 2021 | 13091 | 0.130 |
Why?
|
| Periodontal Index | 2 | 2014 | 152 | 0.130 |
Why?
|
| Occupational Exposure | 6 | 2011 | 1807 | 0.130 |
Why?
|
| Psychiatric Status Rating Scales | 4 | 2020 | 6030 | 0.130 |
Why?
|
| Decision Support Systems, Clinical | 2 | 2020 | 1178 | 0.130 |
Why?
|
| Environmental Monitoring | 6 | 2007 | 1469 | 0.130 |
Why?
|
| Frail Elderly | 2 | 2023 | 781 | 0.130 |
Why?
|
| Inpatients | 3 | 2021 | 2569 | 0.130 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2022 | 644 | 0.130 |
Why?
|
| Proportional Hazards Models | 12 | 2024 | 12562 | 0.130 |
Why?
|
| Cardiac Resynchronization Therapy | 1 | 2022 | 560 | 0.130 |
Why?
|
| Resuscitation | 2 | 2018 | 679 | 0.130 |
Why?
|
| Aneurysm, Ruptured | 1 | 2021 | 462 | 0.130 |
Why?
|
| Physician Assistants | 1 | 2018 | 190 | 0.130 |
Why?
|
| Ambulatory Care | 2 | 2021 | 2784 | 0.130 |
Why?
|
| tau Proteins | 2 | 2024 | 2146 | 0.130 |
Why?
|
| Time | 1 | 1997 | 552 | 0.130 |
Why?
|
| Azo Compounds | 1 | 2015 | 116 | 0.130 |
Why?
|
| Carcinoma, Renal Cell | 4 | 2013 | 3200 | 0.130 |
Why?
|
| Sus scrofa | 4 | 2019 | 430 | 0.120 |
Why?
|
| Audiovisual Aids | 1 | 2016 | 99 | 0.120 |
Why?
|
| Angina Pectoris | 1 | 2019 | 957 | 0.120 |
Why?
|
| Professional-Patient Relations | 1 | 2020 | 725 | 0.120 |
Why?
|
| Decision Making, Computer-Assisted | 1 | 1996 | 146 | 0.120 |
Why?
|
| Brain | 8 | 2023 | 27453 | 0.120 |
Why?
|
| Rural Health Services | 1 | 2019 | 394 | 0.120 |
Why?
|
| Gentamicins | 1 | 1996 | 244 | 0.120 |
Why?
|
| Zirconium | 1 | 2015 | 110 | 0.120 |
Why?
|
| Heart Diseases | 2 | 2019 | 2819 | 0.120 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 4 | 2017 | 560 | 0.120 |
Why?
|
| Cross-Sectional Studies | 15 | 2023 | 26395 | 0.120 |
Why?
|
| Apolipoprotein E4 | 2 | 2020 | 712 | 0.120 |
Why?
|
| Pulmonary Veins | 2 | 2011 | 758 | 0.120 |
Why?
|
| Benchmarking | 1 | 2021 | 1059 | 0.120 |
Why?
|
| Fibrosis | 4 | 2024 | 2080 | 0.120 |
Why?
|
| Proton Pump Inhibitors | 2 | 2011 | 552 | 0.120 |
Why?
|
| Apolipoprotein E2 | 1 | 2015 | 134 | 0.120 |
Why?
|
| Artifacts | 3 | 2012 | 1942 | 0.120 |
Why?
|
| Information Storage and Retrieval | 3 | 2005 | 831 | 0.120 |
Why?
|
| Mitral Valve Prolapse | 1 | 2016 | 213 | 0.120 |
Why?
|
| Sarcoidosis | 1 | 2020 | 535 | 0.120 |
Why?
|
| Health Status | 3 | 2007 | 4095 | 0.120 |
Why?
|
| Information Seeking Behavior | 1 | 2016 | 116 | 0.120 |
Why?
|
| Gastrointestinal Hemorrhage | 2 | 2013 | 1126 | 0.120 |
Why?
|
| Exercise Test | 2 | 2019 | 2187 | 0.120 |
Why?
|
| Endothelial Cells | 3 | 2023 | 3592 | 0.110 |
Why?
|
| Benzoates | 1 | 2015 | 213 | 0.110 |
Why?
|
| Electronic Mail | 1 | 2016 | 215 | 0.110 |
Why?
|
| Respiratory Function Tests | 8 | 2007 | 1694 | 0.110 |
Why?
|
| Kidney Cortex Necrosis | 1 | 2013 | 6 | 0.110 |
Why?
|
| Adipose Tissue | 3 | 2018 | 3335 | 0.110 |
Why?
|
| Multivariate Analysis | 8 | 2025 | 12095 | 0.110 |
Why?
|
| Kidney Neoplasms | 4 | 2013 | 4300 | 0.110 |
Why?
|
| Apolipoproteins E | 1 | 2020 | 1461 | 0.110 |
Why?
|
| Community Health Services | 1 | 2019 | 659 | 0.110 |
Why?
|
| Appointments and Schedules | 1 | 2018 | 443 | 0.110 |
Why?
|
| Signal Processing, Computer-Assisted | 3 | 2016 | 1495 | 0.110 |
Why?
|
| Microcirculation | 1 | 2018 | 1281 | 0.110 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 2 | 2011 | 933 | 0.110 |
Why?
|
| Heart Conduction System | 1 | 2019 | 1009 | 0.110 |
Why?
|
| Shock | 1 | 2016 | 316 | 0.110 |
Why?
|
| Systemic Inflammatory Response Syndrome | 2 | 2011 | 621 | 0.110 |
Why?
|
| Cardiac Imaging Techniques | 1 | 2016 | 280 | 0.110 |
Why?
|
| Pericardium | 1 | 2018 | 679 | 0.110 |
Why?
|
| Analysis of Variance | 7 | 2012 | 6236 | 0.110 |
Why?
|
| Consumer Health Information | 1 | 2016 | 215 | 0.110 |
Why?
|
| Adolescent | 24 | 2024 | 89244 | 0.110 |
Why?
|
| Kidney | 5 | 2023 | 7058 | 0.110 |
Why?
|
| Cerebral Hemorrhage | 1 | 2024 | 2660 | 0.110 |
Why?
|
| Odds Ratio | 5 | 2024 | 9684 | 0.110 |
Why?
|
| Interview, Psychological | 1 | 2016 | 810 | 0.110 |
Why?
|
| Amides | 1 | 2015 | 452 | 0.110 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 2 | 2009 | 558 | 0.110 |
Why?
|
| Blood Glucose | 3 | 2024 | 6435 | 0.100 |
Why?
|
| Affect | 1 | 2020 | 1500 | 0.100 |
Why?
|
| Antacids | 1 | 2013 | 94 | 0.100 |
Why?
|
| Body Surface Potential Mapping | 1 | 2014 | 228 | 0.100 |
Why?
|
| Drug Utilization | 3 | 2013 | 1191 | 0.100 |
Why?
|
| Dysmenorrhea | 2 | 2024 | 107 | 0.100 |
Why?
|
| Vasoconstrictor Agents | 1 | 2016 | 657 | 0.100 |
Why?
|
| Blood Pressure Determination | 3 | 2024 | 646 | 0.100 |
Why?
|
| Amyloid beta-Peptides | 2 | 2024 | 3913 | 0.100 |
Why?
|
| Probability Learning | 1 | 2012 | 23 | 0.100 |
Why?
|
| Hypokinesia | 1 | 2011 | 23 | 0.100 |
Why?
|
| California | 11 | 2006 | 1443 | 0.100 |
Why?
|
| Myocardial Infarction | 4 | 2019 | 11521 | 0.100 |
Why?
|
| Vietnam | 3 | 2019 | 415 | 0.100 |
Why?
|
| Diagnosis, Differential | 6 | 2021 | 13021 | 0.100 |
Why?
|
| Overweight | 2 | 2021 | 2448 | 0.100 |
Why?
|
| Disease Models, Animal | 6 | 2024 | 18354 | 0.100 |
Why?
|
| Environmental Exposure | 5 | 2012 | 4544 | 0.100 |
Why?
|
| Hospital Rapid Response Team | 1 | 2012 | 54 | 0.100 |
Why?
|
| Seizures | 2 | 2015 | 3000 | 0.100 |
Why?
|
| Health Services Research | 2 | 2018 | 1818 | 0.100 |
Why?
|
| Cognition Disorders | 2 | 2016 | 3985 | 0.100 |
Why?
|
| Virus Activation | 2 | 2014 | 324 | 0.100 |
Why?
|
| HIV | 1 | 2019 | 1597 | 0.100 |
Why?
|
| Patient Satisfaction | 2 | 2016 | 3492 | 0.100 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2021 | 2276 | 0.090 |
Why?
|
| Action Potentials | 1 | 2019 | 1838 | 0.090 |
Why?
|
| Colon | 2 | 2010 | 1803 | 0.090 |
Why?
|
| Office Visits | 1 | 2016 | 596 | 0.090 |
Why?
|
| Pseudomonas Infections | 1 | 1996 | 623 | 0.090 |
Why?
|
| Radiography, Thoracic | 2 | 2020 | 1321 | 0.090 |
Why?
|
| Atrial Fibrillation | 4 | 2018 | 5176 | 0.090 |
Why?
|
| Wavelet Analysis | 1 | 2011 | 56 | 0.090 |
Why?
|
| Hydrocortisone | 2 | 2016 | 1841 | 0.090 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2020 | 1892 | 0.090 |
Why?
|
| Fucose | 1 | 2011 | 122 | 0.090 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2024 | 2145 | 0.090 |
Why?
|
| Viral Load | 2 | 2019 | 3398 | 0.090 |
Why?
|
| Socioeconomic Factors | 5 | 2022 | 7861 | 0.090 |
Why?
|
| Critical Illness | 3 | 2012 | 2754 | 0.090 |
Why?
|
| SEER Program | 7 | 2011 | 1473 | 0.090 |
Why?
|
| Embolization, Therapeutic | 1 | 2021 | 1410 | 0.090 |
Why?
|
| ROC Curve | 4 | 2020 | 3629 | 0.090 |
Why?
|
| Acute Kidney Injury | 1 | 2023 | 1936 | 0.090 |
Why?
|
| Nipples | 1 | 2013 | 229 | 0.090 |
Why?
|
| Angiomyolipoma | 1 | 2012 | 189 | 0.090 |
Why?
|
| Adenocarcinoma, Clear Cell | 1 | 2012 | 218 | 0.090 |
Why?
|
| Intracranial Aneurysm | 1 | 2021 | 1293 | 0.090 |
Why?
|
| Prostatic Neoplasms | 5 | 2013 | 11230 | 0.090 |
Why?
|
| Air Pollutants | 4 | 2011 | 2915 | 0.090 |
Why?
|
| Welding | 1 | 2011 | 89 | 0.090 |
Why?
|
| Construction Materials | 3 | 2006 | 60 | 0.090 |
Why?
|
| Pain | 2 | 2021 | 5100 | 0.090 |
Why?
|
| Dizziness | 1 | 2014 | 269 | 0.090 |
Why?
|
| Death, Sudden, Cardiac | 2 | 2023 | 1568 | 0.090 |
Why?
|
| Cone-Beam Computed Tomography | 1 | 2014 | 459 | 0.090 |
Why?
|
| Stochastic Processes | 1 | 2012 | 360 | 0.090 |
Why?
|
| Coronary Disease | 2 | 2023 | 5919 | 0.090 |
Why?
|
| Lactic Acid | 1 | 2016 | 1140 | 0.090 |
Why?
|
| Executive Function | 1 | 2019 | 1405 | 0.090 |
Why?
|
| Periodontitis | 1 | 2015 | 577 | 0.090 |
Why?
|
| Air Pollution | 5 | 2012 | 2372 | 0.090 |
Why?
|
| Cluster Analysis | 1 | 2017 | 2732 | 0.090 |
Why?
|
| Air | 1 | 2010 | 187 | 0.090 |
Why?
|
| Isosorbide Dinitrate | 1 | 2010 | 34 | 0.090 |
Why?
|
| Memory | 1 | 2020 | 2209 | 0.090 |
Why?
|
| Age Factors | 8 | 2024 | 18435 | 0.090 |
Why?
|
| Social Security | 2 | 2007 | 101 | 0.080 |
Why?
|
| Electric Countershock | 1 | 2013 | 534 | 0.080 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2020 | 20776 | 0.080 |
Why?
|
| Magnetic Resonance Spectroscopy | 4 | 2024 | 3782 | 0.080 |
Why?
|
| Kaplan-Meier Estimate | 5 | 2013 | 6547 | 0.080 |
Why?
|
| Mental Recall | 1 | 2016 | 1226 | 0.080 |
Why?
|
| Integrin alpha4 | 1 | 2009 | 88 | 0.080 |
Why?
|
| Rectal Diseases | 1 | 2010 | 142 | 0.080 |
Why?
|
| Nonlinear Dynamics | 1 | 2012 | 494 | 0.080 |
Why?
|
| Cerebellar Diseases | 1 | 2011 | 228 | 0.080 |
Why?
|
| Survivors | 2 | 2020 | 2383 | 0.080 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2025 | 3683 | 0.080 |
Why?
|
| Radiation Protection | 1 | 2013 | 428 | 0.080 |
Why?
|
| Atrial Natriuretic Factor | 1 | 1990 | 350 | 0.080 |
Why?
|
| Urban Health Services | 1 | 2010 | 177 | 0.080 |
Why?
|
| DNA Damage | 3 | 2010 | 2472 | 0.080 |
Why?
|
| Ebolavirus | 1 | 2011 | 250 | 0.080 |
Why?
|
| Computer Simulation | 4 | 2010 | 6291 | 0.080 |
Why?
|
| Pneumonia | 2 | 2012 | 2164 | 0.080 |
Why?
|
| Linear Models | 7 | 2016 | 5891 | 0.080 |
Why?
|
| Tachycardia, Ventricular | 1 | 2017 | 1309 | 0.080 |
Why?
|
| Parkinsonian Disorders | 1 | 2011 | 285 | 0.080 |
Why?
|
| Protein C | 1 | 2009 | 134 | 0.080 |
Why?
|
| Image Processing, Computer-Assisted | 6 | 2017 | 9080 | 0.080 |
Why?
|
| Pyrenes | 2 | 2007 | 51 | 0.080 |
Why?
|
| Emergency Treatment | 3 | 2007 | 497 | 0.080 |
Why?
|
| Intensive Care Units | 4 | 2016 | 3800 | 0.080 |
Why?
|
| Interviews as Topic | 3 | 2015 | 2744 | 0.080 |
Why?
|
| Terminology as Topic | 2 | 2006 | 1541 | 0.080 |
Why?
|
| Depression | 2 | 2022 | 8231 | 0.080 |
Why?
|
| Capsid Proteins | 1 | 2011 | 468 | 0.080 |
Why?
|
| Prospective Payment System | 1 | 2009 | 136 | 0.070 |
Why?
|
| Pseudomonas aeruginosa | 1 | 1996 | 1276 | 0.070 |
Why?
|
| Interleukin-1 | 2 | 2009 | 1251 | 0.070 |
Why?
|
| Artificial Intelligence | 4 | 2012 | 2666 | 0.070 |
Why?
|
| Drug Prescriptions | 2 | 2024 | 1673 | 0.070 |
Why?
|
| Lipocalins | 1 | 2009 | 161 | 0.070 |
Why?
|
| Inhalation Exposure | 3 | 2006 | 432 | 0.070 |
Why?
|
| Biopsy, Needle | 1 | 2013 | 1626 | 0.070 |
Why?
|
| Tachycardia, Supraventricular | 1 | 1990 | 273 | 0.070 |
Why?
|
| Mortality | 3 | 2016 | 2914 | 0.070 |
Why?
|
| Information Dissemination | 1 | 2016 | 1141 | 0.070 |
Why?
|
| Phenotype | 2 | 2023 | 16731 | 0.070 |
Why?
|
| Atherosclerosis | 1 | 2023 | 3431 | 0.070 |
Why?
|
| Preoperative Care | 2 | 2016 | 2258 | 0.070 |
Why?
|
| Internationality | 1 | 2013 | 1008 | 0.070 |
Why?
|
| Hydroxamic Acids | 1 | 2010 | 483 | 0.070 |
Why?
|
| Health Services for the Aged | 1 | 2010 | 264 | 0.070 |
Why?
|
| Virus Latency | 1 | 2010 | 360 | 0.070 |
Why?
|
| Quality of Life | 3 | 2023 | 13510 | 0.070 |
Why?
|
| Pulmonary Medicine | 1 | 2009 | 223 | 0.070 |
Why?
|
| Sodium Radioisotopes | 1 | 2006 | 6 | 0.070 |
Why?
|
| Academic Medical Centers | 4 | 2013 | 2784 | 0.070 |
Why?
|
| Data Mining | 1 | 2012 | 563 | 0.070 |
Why?
|
| Sequence Deletion | 1 | 2011 | 1498 | 0.070 |
Why?
|
| Patient-Centered Care | 1 | 2017 | 1447 | 0.070 |
Why?
|
| Occupational Health Services | 1 | 2008 | 149 | 0.070 |
Why?
|
| Treatment Outcome | 13 | 2024 | 65480 | 0.070 |
Why?
|
| Telephone | 2 | 2009 | 630 | 0.070 |
Why?
|
| Patient Admission | 2 | 2012 | 1370 | 0.070 |
Why?
|
| Length of Stay | 6 | 2021 | 6526 | 0.070 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2012 | 709 | 0.070 |
Why?
|
| Aorta, Thoracic | 1 | 2013 | 1112 | 0.070 |
Why?
|
| Endovascular Procedures | 1 | 2021 | 2218 | 0.070 |
Why?
|
| Cognition | 6 | 2023 | 7081 | 0.070 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2017 | 2426 | 0.070 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2009 | 243 | 0.070 |
Why?
|
| Carcinoma, Lobular | 1 | 2011 | 480 | 0.070 |
Why?
|
| Lymphatic Vessels | 1 | 2011 | 356 | 0.070 |
Why?
|
| Health Services Accessibility | 2 | 2019 | 5522 | 0.070 |
Why?
|
| Budgets | 1 | 2008 | 232 | 0.070 |
Why?
|
| Muscular Diseases | 1 | 2011 | 553 | 0.070 |
Why?
|
| DNA, Viral | 2 | 2010 | 2205 | 0.070 |
Why?
|
| Veins | 1 | 2010 | 769 | 0.070 |
Why?
|
| DNA Adducts | 1 | 2006 | 95 | 0.070 |
Why?
|
| Antipsychotic Agents | 1 | 2019 | 3081 | 0.070 |
Why?
|
| Vaginal Creams, Foams, and Jellies | 1 | 2006 | 62 | 0.070 |
Why?
|
| Population Surveillance | 1 | 2016 | 2597 | 0.060 |
Why?
|
| Cell Differentiation | 2 | 2021 | 11684 | 0.060 |
Why?
|
| Clinical Competence | 3 | 2018 | 4860 | 0.060 |
Why?
|
| Body Mass Index | 6 | 2021 | 13055 | 0.060 |
Why?
|
| Health Care Surveys | 1 | 2013 | 2437 | 0.060 |
Why?
|
| Bronchiolitis | 1 | 2012 | 492 | 0.060 |
Why?
|
| Anticonvulsants | 1 | 2015 | 1924 | 0.060 |
Why?
|
| Editorial Policies | 3 | 2018 | 460 | 0.060 |
Why?
|
| Cerebrovascular Circulation | 1 | 2016 | 2734 | 0.060 |
Why?
|
| Attitude to Health | 1 | 2014 | 2025 | 0.060 |
Why?
|
| Subtraction Technique | 1 | 2008 | 519 | 0.060 |
Why?
|
| Vasodilator Agents | 1 | 2010 | 990 | 0.060 |
Why?
|
| Mastectomy, Segmental | 2 | 2010 | 960 | 0.060 |
Why?
|
| Heart Ventricles | 1 | 2017 | 3840 | 0.060 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2010 | 778 | 0.060 |
Why?
|
| Hospitals | 2 | 2021 | 3904 | 0.060 |
Why?
|
| Eligibility Determination | 1 | 2009 | 421 | 0.060 |
Why?
|
| Swine | 4 | 2024 | 5997 | 0.060 |
Why?
|
| Vocabulary | 1 | 2006 | 167 | 0.060 |
Why?
|
| Vascular Endothelial Growth Factor A | 3 | 2017 | 3518 | 0.060 |
Why?
|
| Medical Order Entry Systems | 1 | 2010 | 523 | 0.060 |
Why?
|
| Catheter Ablation | 1 | 2018 | 2780 | 0.060 |
Why?
|
| Pennsylvania | 2 | 2019 | 615 | 0.060 |
Why?
|
| Delivery of Health Care | 1 | 2023 | 5375 | 0.060 |
Why?
|
| Regression Analysis | 6 | 2015 | 6346 | 0.060 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2011 | 3253 | 0.060 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2019 | 3235 | 0.060 |
Why?
|
| Lung Diseases | 2 | 2019 | 1944 | 0.060 |
Why?
|
| Critical Care | 2 | 2021 | 2716 | 0.060 |
Why?
|
| Financing, Government | 1 | 2008 | 473 | 0.060 |
Why?
|
| Radiation Dosage | 1 | 2013 | 1970 | 0.060 |
Why?
|
| Physical Therapy Modalities | 1 | 2008 | 533 | 0.060 |
Why?
|
| Word Processing | 1 | 2004 | 7 | 0.060 |
Why?
|
| Automation | 1 | 2007 | 589 | 0.060 |
Why?
|
| Echo-Planar Imaging | 1 | 2008 | 674 | 0.060 |
Why?
|
| Medication Errors | 1 | 2010 | 785 | 0.060 |
Why?
|
| Electrocardiography | 5 | 2019 | 6413 | 0.060 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2016 | 2831 | 0.060 |
Why?
|
| Lymph Nodes | 3 | 2011 | 3473 | 0.060 |
Why?
|
| MEDLINE | 1 | 2004 | 119 | 0.060 |
Why?
|
| Pregnancy | 4 | 2023 | 30265 | 0.060 |
Why?
|
| Deoxyguanosine | 1 | 2004 | 96 | 0.060 |
Why?
|
| Hazardous Substances | 2 | 2002 | 153 | 0.060 |
Why?
|
| Kidney Diseases | 2 | 2011 | 2100 | 0.060 |
Why?
|
| User-Computer Interface | 2 | 2007 | 1406 | 0.060 |
Why?
|
| Bayes Theorem | 4 | 2011 | 2360 | 0.060 |
Why?
|
| Medication Adherence | 1 | 2015 | 2192 | 0.050 |
Why?
|
| Mutagens | 1 | 2004 | 181 | 0.050 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2006 | 247 | 0.050 |
Why?
|
| Language Tests | 1 | 2004 | 193 | 0.050 |
Why?
|
| Hip Fractures | 2 | 2010 | 997 | 0.050 |
Why?
|
| Arthritis | 1 | 2009 | 684 | 0.050 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2011 | 1093 | 0.050 |
Why?
|
| Cerebrospinal Fluid Proteins | 1 | 2023 | 71 | 0.050 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2007 | 4056 | 0.050 |
Why?
|
| Mental Status Schedule | 1 | 2004 | 315 | 0.050 |
Why?
|
| Neoplasm Staging | 8 | 2011 | 11262 | 0.050 |
Why?
|
| Laryngeal Muscles | 1 | 2024 | 107 | 0.050 |
Why?
|
| Health Status Indicators | 2 | 2006 | 971 | 0.050 |
Why?
|
| Probability | 3 | 2023 | 2483 | 0.050 |
Why?
|
| DNA Repair | 2 | 2010 | 2054 | 0.050 |
Why?
|
| Family | 3 | 2024 | 3208 | 0.050 |
Why?
|
| Natural Language Processing | 1 | 2012 | 1203 | 0.050 |
Why?
|
| Body Composition | 2 | 2023 | 2462 | 0.050 |
Why?
|
| Patient Readmission | 3 | 2024 | 3313 | 0.050 |
Why?
|
| Prejudice | 1 | 2007 | 574 | 0.050 |
Why?
|
| Dementia, Vascular | 1 | 2004 | 125 | 0.050 |
Why?
|
| Carotid Arteries | 1 | 2007 | 943 | 0.050 |
Why?
|
| Smoking | 4 | 2012 | 9094 | 0.050 |
Why?
|
| Anti-HIV Agents | 1 | 2019 | 4576 | 0.050 |
Why?
|
| Speech Disorders | 1 | 2004 | 180 | 0.050 |
Why?
|
| Movement Disorders | 1 | 2006 | 464 | 0.050 |
Why?
|
| Statistics, Nonparametric | 4 | 2012 | 2862 | 0.050 |
Why?
|
| Social Class | 1 | 2011 | 2009 | 0.050 |
Why?
|
| British Columbia | 1 | 2022 | 240 | 0.050 |
Why?
|
| Vehicle Emissions | 1 | 2007 | 651 | 0.050 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2011 | 4413 | 0.050 |
Why?
|
| Health Surveys | 4 | 2007 | 4055 | 0.050 |
Why?
|
| Cerebral Ventricles | 1 | 2024 | 550 | 0.050 |
Why?
|
| Hospitals, Urban | 3 | 2009 | 499 | 0.050 |
Why?
|
| Neurodegenerative Diseases | 1 | 2011 | 1094 | 0.050 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2011 | 1751 | 0.050 |
Why?
|
| Demography | 1 | 2007 | 1642 | 0.050 |
Why?
|
| Data Interpretation, Statistical | 1 | 2012 | 2714 | 0.050 |
Why?
|
| Educational Status | 4 | 2016 | 2515 | 0.050 |
Why?
|
| Prevalence | 7 | 2019 | 15879 | 0.050 |
Why?
|
| Surgical Flaps | 1 | 2010 | 1682 | 0.050 |
Why?
|
| Muscle, Skeletal | 2 | 2011 | 4978 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2024 | 10400 | 0.050 |
Why?
|
| Quantum Theory | 1 | 2001 | 68 | 0.050 |
Why?
|
| Coronary Artery Disease | 2 | 2019 | 6569 | 0.050 |
Why?
|
| Sodium | 1 | 2006 | 1597 | 0.050 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2023 | 252 | 0.050 |
Why?
|
| Liver Cirrhosis | 1 | 2011 | 1962 | 0.050 |
Why?
|
| Principal Component Analysis | 1 | 2024 | 948 | 0.050 |
Why?
|
| Lamin Type A | 1 | 2022 | 190 | 0.050 |
Why?
|
| Area Under Curve | 2 | 2020 | 1645 | 0.050 |
Why?
|
| Massachusetts | 4 | 2019 | 8894 | 0.040 |
Why?
|
| Ventricular Remodeling | 2 | 2019 | 1282 | 0.040 |
Why?
|
| Syncope | 1 | 2023 | 430 | 0.040 |
Why?
|
| Musculoskeletal Diseases | 1 | 2006 | 599 | 0.040 |
Why?
|
| Hemodynamics | 4 | 2018 | 4199 | 0.040 |
Why?
|
| Bronchial Hyperreactivity | 1 | 2001 | 301 | 0.040 |
Why?
|
| Carbon | 1 | 2004 | 672 | 0.040 |
Why?
|
| Oligonucleotides | 1 | 2023 | 563 | 0.040 |
Why?
|
| Mammaplasty | 1 | 2010 | 1263 | 0.040 |
Why?
|
| Anxiety | 2 | 2014 | 4672 | 0.040 |
Why?
|
| Animals | 16 | 2024 | 169335 | 0.040 |
Why?
|
| Colonoscopy | 1 | 2008 | 1410 | 0.040 |
Why?
|
| Selection Bias | 1 | 2022 | 360 | 0.040 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2024 | 682 | 0.040 |
Why?
|
| Treatment Failure | 2 | 2020 | 2664 | 0.040 |
Why?
|
| Reference Standards | 1 | 2023 | 1014 | 0.040 |
Why?
|
| Hypernatremia | 1 | 2020 | 78 | 0.040 |
Why?
|
| Sexually Transmitted Diseases | 1 | 2006 | 668 | 0.040 |
Why?
|
| Vaginal Smears | 1 | 2003 | 505 | 0.040 |
Why?
|
| Coronary Artery Bypass | 3 | 1999 | 2194 | 0.040 |
Why?
|
| Emotions | 2 | 2023 | 2768 | 0.040 |
Why?
|
| Coculture Techniques | 1 | 2023 | 1342 | 0.040 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2022 | 262 | 0.040 |
Why?
|
| Cooperative Behavior | 1 | 2007 | 1515 | 0.040 |
Why?
|
| Phenylalanine-tRNA Ligase | 1 | 1999 | 15 | 0.040 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 2 | 2011 | 279 | 0.040 |
Why?
|
| Brachytherapy | 1 | 2007 | 1224 | 0.040 |
Why?
|
| Tennessee | 1 | 2019 | 123 | 0.040 |
Why?
|
| Drug Therapy | 1 | 2002 | 504 | 0.040 |
Why?
|
| Stroke | 2 | 2014 | 9756 | 0.040 |
Why?
|
| Menopause | 1 | 2007 | 1656 | 0.040 |
Why?
|
| Hand Strength | 1 | 2002 | 466 | 0.040 |
Why?
|
| Biopsy | 3 | 2024 | 6805 | 0.040 |
Why?
|
| England | 1 | 2020 | 533 | 0.040 |
Why?
|
| Motion | 2 | 2013 | 794 | 0.040 |
Why?
|
| Catheterization, Swan-Ganz | 1 | 1999 | 87 | 0.040 |
Why?
|
| Child, Preschool | 6 | 2024 | 42683 | 0.040 |
Why?
|
| Appendicitis | 1 | 2006 | 689 | 0.040 |
Why?
|
| Intraoperative Period | 2 | 2010 | 513 | 0.040 |
Why?
|
| Risk | 4 | 2015 | 9621 | 0.040 |
Why?
|
| Supine Position | 1 | 2019 | 208 | 0.040 |
Why?
|
| Thinness | 1 | 2002 | 483 | 0.040 |
Why?
|
| Electromyography | 1 | 2024 | 1401 | 0.040 |
Why?
|
| Radiotherapy, Adjuvant | 3 | 2010 | 1793 | 0.040 |
Why?
|
| Dental Caries | 1 | 2003 | 429 | 0.040 |
Why?
|
| Plasma | 1 | 2022 | 585 | 0.040 |
Why?
|
| Endothelium, Vascular | 1 | 2011 | 4428 | 0.040 |
Why?
|
| Proteins | 2 | 2012 | 6011 | 0.040 |
Why?
|
| Seasons | 3 | 2012 | 1524 | 0.040 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2001 | 508 | 0.040 |
Why?
|
| Health Services | 1 | 2004 | 755 | 0.040 |
Why?
|
| Leukocytes | 1 | 2006 | 2034 | 0.040 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2020 | 564 | 0.040 |
Why?
|
| Thrombolytic Therapy | 1 | 2007 | 2055 | 0.040 |
Why?
|
| Fatty Liver | 1 | 2024 | 810 | 0.040 |
Why?
|
| Immunologic Factors | 1 | 2007 | 1597 | 0.040 |
Why?
|
| Diet, Reducing | 1 | 2021 | 487 | 0.040 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 2 | 2011 | 692 | 0.040 |
Why?
|
| Canada | 1 | 2023 | 2130 | 0.040 |
Why?
|
| Models, Theoretical | 2 | 2007 | 3580 | 0.040 |
Why?
|
| Tissue Survival | 1 | 2018 | 120 | 0.040 |
Why?
|
| Preventive Health Services | 1 | 2003 | 570 | 0.040 |
Why?
|
| Intracranial Hemorrhages | 1 | 2023 | 811 | 0.040 |
Why?
|
| Myositis Ossificans | 1 | 1999 | 77 | 0.040 |
Why?
|
| Hospitals, University | 2 | 2012 | 570 | 0.040 |
Why?
|
| Chi-Square Distribution | 3 | 2012 | 3438 | 0.040 |
Why?
|
| Magnesium | 1 | 2001 | 816 | 0.040 |
Why?
|
| Tobacco Smoke Pollution | 2 | 2001 | 828 | 0.040 |
Why?
|
| Neuroglia | 1 | 2023 | 960 | 0.040 |
Why?
|
| Cerebral Cortex | 1 | 2014 | 5831 | 0.040 |
Why?
|
| Respiration | 2 | 2013 | 1668 | 0.040 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2011 | 3253 | 0.040 |
Why?
|
| Creatinine | 1 | 2023 | 1917 | 0.040 |
Why?
|
| Fluorescence | 2 | 2011 | 757 | 0.040 |
Why?
|
| Logic | 1 | 1997 | 40 | 0.040 |
Why?
|
| Communicable Diseases | 1 | 2006 | 873 | 0.040 |
Why?
|
| Insurance, Health | 2 | 2007 | 2518 | 0.040 |
Why?
|
| Child | 5 | 2024 | 80960 | 0.040 |
Why?
|
| Survival Rate | 5 | 2016 | 12873 | 0.040 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2011 | 4651 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 1 | 1996 | 7478 | 0.040 |
Why?
|
| Databases, Factual | 3 | 2021 | 8094 | 0.030 |
Why?
|
| Acute Disease | 3 | 2012 | 7245 | 0.030 |
Why?
|
| Homes for the Aged | 1 | 2019 | 273 | 0.030 |
Why?
|
| Statistics as Topic | 2 | 2017 | 2360 | 0.030 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2001 | 365 | 0.030 |
Why?
|
| Abdominal Pain | 1 | 2023 | 1070 | 0.030 |
Why?
|
| Urine | 2 | 2009 | 362 | 0.030 |
Why?
|
| Cysteine | 1 | 2021 | 897 | 0.030 |
Why?
|
| Physical Fitness | 2 | 1998 | 744 | 0.030 |
Why?
|
| Aging | 3 | 2021 | 8745 | 0.030 |
Why?
|
| Qualitative Research | 2 | 2021 | 3143 | 0.030 |
Why?
|
| Patient Positioning | 1 | 2019 | 332 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2018 | 18068 | 0.030 |
Why?
|
| Motor Activity | 1 | 2006 | 2713 | 0.030 |
Why?
|
| Alleles | 2 | 2020 | 6901 | 0.030 |
Why?
|
| Air Pollution, Indoor | 1 | 2004 | 931 | 0.030 |
Why?
|
| Thrombomodulin | 1 | 2017 | 107 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2009 | 4528 | 0.030 |
Why?
|
| Eating | 1 | 2023 | 1542 | 0.030 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2019 | 511 | 0.030 |
Why?
|
| Patient Care | 1 | 2022 | 629 | 0.030 |
Why?
|
| Fractures, Bone | 1 | 2008 | 2063 | 0.030 |
Why?
|
| Documentation | 1 | 2022 | 917 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 2 | 2011 | 9264 | 0.030 |
Why?
|
| Chloroplasts | 1 | 1996 | 46 | 0.030 |
Why?
|
| Catecholamines | 1 | 1997 | 389 | 0.030 |
Why?
|
| Radionuclide Imaging | 2 | 2011 | 1998 | 0.030 |
Why?
|
| San Francisco | 1 | 1996 | 166 | 0.030 |
Why?
|
| Aftercare | 1 | 2022 | 921 | 0.030 |
Why?
|
| Collagen | 1 | 2024 | 2646 | 0.030 |
Why?
|
| Guideline Adherence | 1 | 2006 | 2241 | 0.030 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2014 | 5716 | 0.030 |
Why?
|
| Angiopoietin-2 | 1 | 2017 | 186 | 0.030 |
Why?
|
| Proton-Translocating ATPases | 1 | 1996 | 112 | 0.030 |
Why?
|
| Sentinel Lymph Node Biopsy | 2 | 2011 | 737 | 0.030 |
Why?
|
| Poisoning | 1 | 1997 | 252 | 0.030 |
Why?
|
| Morbidity | 1 | 2021 | 1757 | 0.030 |
Why?
|
| Medical Illustration | 1 | 2016 | 135 | 0.030 |
Why?
|
| Therapy, Computer-Assisted | 1 | 1997 | 265 | 0.030 |
Why?
|
| CD4 Lymphocyte Count | 2 | 2019 | 2598 | 0.030 |
Why?
|
| Benzodiazepines | 1 | 2021 | 1138 | 0.030 |
Why?
|
| Thrombophlebitis | 1 | 1996 | 289 | 0.030 |
Why?
|
| Exercise | 2 | 2011 | 5954 | 0.030 |
Why?
|
| Normal Distribution | 2 | 2011 | 272 | 0.030 |
Why?
|
| Walking | 1 | 2002 | 1201 | 0.030 |
Why?
|
| Molecular Sequence Data | 5 | 2011 | 17629 | 0.030 |
Why?
|
| Permeability | 1 | 2017 | 726 | 0.030 |
Why?
|
| Multicenter Studies as Topic | 1 | 2020 | 1737 | 0.030 |
Why?
|
| Furans | 1 | 2015 | 202 | 0.030 |
Why?
|
| Health Behavior | 1 | 2006 | 2649 | 0.030 |
Why?
|
| Skin Absorption | 2 | 2004 | 96 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2020 | 1913 | 0.030 |
Why?
|
| Lung | 3 | 1998 | 10099 | 0.030 |
Why?
|
| Nitric Acid | 1 | 1993 | 10 | 0.030 |
Why?
|
| Numerical Analysis, Computer-Assisted | 1 | 2014 | 119 | 0.030 |
Why?
|
| Hemostasis | 1 | 2017 | 468 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2019 | 1194 | 0.030 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2019 | 1141 | 0.030 |
Why?
|
| Infant | 5 | 2012 | 36556 | 0.030 |
Why?
|
| Catalysis | 1 | 2015 | 768 | 0.030 |
Why?
|
| Forecasting | 2 | 2009 | 2945 | 0.030 |
Why?
|
| Subacute Care | 1 | 2016 | 188 | 0.030 |
Why?
|
| Survival Analysis | 4 | 2012 | 10115 | 0.030 |
Why?
|
| Gingivitis | 1 | 2014 | 125 | 0.030 |
Why?
|
| Myocardial Contraction | 1 | 2019 | 1526 | 0.030 |
Why?
|
| Neoplasms | 4 | 2019 | 22389 | 0.030 |
Why?
|
| Infant, Newborn | 3 | 2012 | 26428 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2018 | 1830 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2021 | 2204 | 0.030 |
Why?
|
| Life Expectancy | 2 | 2011 | 1249 | 0.030 |
Why?
|
| Renal Veins | 1 | 2013 | 103 | 0.030 |
Why?
|
| Pain, Postoperative | 1 | 2024 | 1767 | 0.030 |
Why?
|
| Monitoring, Physiologic | 2 | 1999 | 1798 | 0.030 |
Why?
|
| Myocardial Perfusion Imaging | 1 | 2019 | 672 | 0.030 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2021 | 1039 | 0.030 |
Why?
|
| Genotype | 2 | 2020 | 13048 | 0.030 |
Why?
|
| Drug Resistance, Microbial | 1 | 1996 | 830 | 0.030 |
Why?
|
| Vasculitis | 1 | 1997 | 525 | 0.030 |
Why?
|
| von Willebrand Factor | 1 | 2017 | 680 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2004 | 3139 | 0.030 |
Why?
|
| Information Services | 2 | 2004 | 239 | 0.030 |
Why?
|
| Health Resources | 1 | 2019 | 951 | 0.030 |
Why?
|
| Methylene Blue | 1 | 2013 | 156 | 0.030 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2008 | 5434 | 0.030 |
Why?
|
| Reference Values | 2 | 2016 | 4940 | 0.030 |
Why?
|
| Software | 2 | 1997 | 4479 | 0.030 |
Why?
|
| Recurrence | 2 | 2018 | 8513 | 0.020 |
Why?
|
| Journal Impact Factor | 1 | 2013 | 156 | 0.020 |
Why?
|
| Lymphatic Metastasis | 2 | 2011 | 2916 | 0.020 |
Why?
|
| Chronic Disease | 2 | 2024 | 9384 | 0.020 |
Why?
|
| Laparoscopy | 1 | 2024 | 2055 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2016 | 1586 | 0.020 |
Why?
|
| Psychomotor Performance | 1 | 2020 | 1894 | 0.020 |
Why?
|
| False Negative Reactions | 1 | 2013 | 575 | 0.020 |
Why?
|
| Perfusion Imaging | 1 | 2013 | 196 | 0.020 |
Why?
|
| Genes, ras | 1 | 1994 | 665 | 0.020 |
Why?
|
| Washington | 1 | 2012 | 315 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2014 | 963 | 0.020 |
Why?
|
| Pregnancy Complications | 1 | 2006 | 2974 | 0.020 |
Why?
|
| Down-Regulation | 1 | 1999 | 2942 | 0.020 |
Why?
|
| Confined Spaces | 1 | 2011 | 10 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 1998 | 1883 | 0.020 |
Why?
|
| Manganese Poisoning | 1 | 2011 | 13 | 0.020 |
Why?
|
| Health | 2 | 2005 | 398 | 0.020 |
Why?
|
| Complement C1q | 1 | 2011 | 93 | 0.020 |
Why?
|
| Geography | 1 | 2013 | 654 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2015 | 1885 | 0.020 |
Why?
|
| Sequence Alignment | 2 | 2011 | 2179 | 0.020 |
Why?
|
| Phosphorus Isotopes | 1 | 2011 | 125 | 0.020 |
Why?
|
| Propofol | 1 | 1997 | 608 | 0.020 |
Why?
|
| Ohio | 1 | 2011 | 321 | 0.020 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2017 | 1165 | 0.020 |
Why?
|
| Surface Plasmon Resonance | 1 | 2011 | 272 | 0.020 |
Why?
|
| Semantics | 2 | 2005 | 618 | 0.020 |
Why?
|
| Pharmaceutical Preparations | 1 | 2019 | 1088 | 0.020 |
Why?
|
| Sex Factors | 3 | 2013 | 10633 | 0.020 |
Why?
|
| Foreskin | 1 | 2010 | 33 | 0.020 |
Why?
|
| Least-Squares Analysis | 1 | 2011 | 367 | 0.020 |
Why?
|
| Urban Population | 2 | 2010 | 2046 | 0.020 |
Why?
|
| Peer Review, Research | 1 | 2013 | 344 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 2 | 2010 | 3554 | 0.020 |
Why?
|
| Antineoplastic Agents | 2 | 2010 | 13698 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2020 | 6320 | 0.020 |
Why?
|
| Administration, Sublingual | 1 | 2010 | 60 | 0.020 |
Why?
|
| Encephalitis | 1 | 2014 | 441 | 0.020 |
Why?
|
| Radiopharmaceuticals | 2 | 2011 | 2734 | 0.020 |
Why?
|
| Pain Measurement | 2 | 2013 | 3586 | 0.020 |
Why?
|
| Factor Analysis, Statistical | 1 | 2013 | 1002 | 0.020 |
Why?
|
| New York | 1 | 2012 | 884 | 0.020 |
Why?
|
| Weight Loss | 1 | 2021 | 2721 | 0.020 |
Why?
|
| Amino Acid Sequence | 4 | 2011 | 13427 | 0.020 |
Why?
|
| Radioimmunoassay | 1 | 1990 | 862 | 0.020 |
Why?
|
| Respiratory Tract Diseases | 1 | 1995 | 744 | 0.020 |
Why?
|
| Family Relations | 1 | 2012 | 318 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 1994 | 1609 | 0.020 |
Why?
|
| Organ Size | 1 | 2015 | 2268 | 0.020 |
Why?
|
| Technetium Tc 99m Sulfur Colloid | 1 | 2009 | 63 | 0.020 |
Why?
|
| Body Weight | 2 | 2015 | 4628 | 0.020 |
Why?
|
| Atrophy | 1 | 2015 | 1647 | 0.020 |
Why?
|
| Cyclins | 1 | 1992 | 606 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2021 | 8559 | 0.020 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 1992 | 582 | 0.020 |
Why?
|
| Privacy | 1 | 2011 | 233 | 0.020 |
Why?
|
| Patient Selection | 2 | 2013 | 4265 | 0.020 |
Why?
|
| Immunization, Passive | 1 | 2011 | 619 | 0.020 |
Why?
|
| Infrared Rays | 1 | 2010 | 249 | 0.020 |
Why?
|
| Hospital Departments | 1 | 2009 | 135 | 0.020 |
Why?
|
| Models, Cardiovascular | 1 | 1995 | 983 | 0.020 |
Why?
|
| Anti-Retroviral Agents | 1 | 2019 | 1795 | 0.020 |
Why?
|
| Poverty | 2 | 2012 | 2720 | 0.020 |
Why?
|
| Spleen | 2 | 2010 | 2294 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2011 | 930 | 0.020 |
Why?
|
| Data Collection | 2 | 2009 | 3324 | 0.020 |
Why?
|
| Hypnotics and Sedatives | 1 | 1997 | 1191 | 0.020 |
Why?
|
| Insurance Coverage | 1 | 2020 | 1946 | 0.020 |
Why?
|
| Peer Review | 1 | 2011 | 219 | 0.020 |
Why?
|
| Computational Biology | 1 | 2021 | 3562 | 0.020 |
Why?
|
| E-Selectin | 1 | 2011 | 578 | 0.020 |
Why?
|
| Glycosylation | 1 | 2011 | 1101 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 2010 | 1379 | 0.020 |
Why?
|
| Signal Transduction | 2 | 2010 | 23653 | 0.020 |
Why?
|
| Confidentiality | 1 | 2012 | 606 | 0.020 |
Why?
|
| Rural Population | 1 | 2019 | 2325 | 0.020 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2016 | 997 | 0.020 |
Why?
|
| Phylogeny | 1 | 1996 | 2843 | 0.020 |
Why?
|
| Molecular Weight | 1 | 1990 | 2173 | 0.020 |
Why?
|
| HIV-1 | 2 | 1997 | 6962 | 0.020 |
Why?
|
| Insurance, Medigap | 1 | 2007 | 20 | 0.020 |
Why?
|
| Tachycardia | 1 | 1990 | 599 | 0.020 |
Why?
|
| Adiposity | 1 | 2018 | 1895 | 0.020 |
Why?
|
| Mice | 7 | 2023 | 82072 | 0.020 |
Why?
|
| Acute-Phase Proteins | 1 | 2009 | 252 | 0.020 |
Why?
|
| Prosthesis Failure | 1 | 2013 | 1209 | 0.020 |
Why?
|
| Acetylation | 1 | 2010 | 1056 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2023 | 9549 | 0.020 |
Why?
|
| APACHE | 1 | 2008 | 268 | 0.020 |
Why?
|
| Coronary Angiography | 1 | 2019 | 4541 | 0.020 |
Why?
|
| Gasoline | 1 | 2007 | 49 | 0.020 |
Why?
|
| Environmental Pollutants | 1 | 1997 | 1296 | 0.020 |
Why?
|
| Bibliometrics | 1 | 2011 | 355 | 0.020 |
Why?
|
| Spin Labels | 1 | 2008 | 339 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2010 | 1647 | 0.020 |
Why?
|
| Transplantation Conditioning | 1 | 2014 | 1601 | 0.020 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2011 | 1133 | 0.020 |
Why?
|
| HIV Seropositivity | 1 | 2012 | 967 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2012 | 2932 | 0.020 |
Why?
|
| Lung Neoplasms | 2 | 2008 | 13594 | 0.020 |
Why?
|
| Workload | 1 | 2012 | 852 | 0.020 |
Why?
|
| Hemorrhagic Fever, Ebola | 1 | 2011 | 424 | 0.020 |
Why?
|
| Disease Outbreaks | 1 | 1996 | 1761 | 0.020 |
Why?
|
| Viremia | 1 | 2009 | 725 | 0.020 |
Why?
|
| Immune System | 1 | 2011 | 800 | 0.020 |
Why?
|
| Dissent and Disputes | 1 | 2007 | 150 | 0.020 |
Why?
|
| Solubility | 1 | 2008 | 1087 | 0.020 |
Why?
|
| Costs and Cost Analysis | 1 | 2011 | 1669 | 0.020 |
Why?
|
| Administration, Intravaginal | 1 | 2006 | 149 | 0.020 |
Why?
|
| Prosthesis Design | 1 | 2013 | 2126 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 1996 | 2960 | 0.020 |
Why?
|
| Emergencies | 1 | 2012 | 1221 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 2010 | 2231 | 0.020 |
Why?
|
| Syndrome | 1 | 2012 | 3274 | 0.020 |
Why?
|
| Cross-Over Studies | 1 | 2012 | 2108 | 0.020 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2010 | 608 | 0.020 |
Why?
|
| Cell Cycle | 2 | 2010 | 2937 | 0.020 |
Why?
|
| Pharmacoepidemiology | 1 | 2009 | 351 | 0.020 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2011 | 752 | 0.020 |
Why?
|
| Marital Status | 1 | 2007 | 426 | 0.020 |
Why?
|
| Work | 1 | 2006 | 195 | 0.020 |
Why?
|
| Health Maintenance Organizations | 1 | 2008 | 657 | 0.020 |
Why?
|
| Geriatrics | 1 | 2010 | 394 | 0.020 |
Why?
|
| Transplantation, Homologous | 1 | 2014 | 4835 | 0.020 |
Why?
|
| Glasgow Coma Scale | 1 | 2007 | 579 | 0.020 |
Why?
|
| Gene Rearrangement | 1 | 2010 | 1148 | 0.020 |
Why?
|
| Quality of Health Care | 2 | 2011 | 4339 | 0.020 |
Why?
|
| Urea | 1 | 2007 | 448 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 2007 | 1629 | 0.010 |
Why?
|
| Neurons | 2 | 2011 | 9519 | 0.010 |
Why?
|
| Bacteria | 1 | 1996 | 2216 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 2011 | 1794 | 0.010 |
Why?
|
| Life Style | 1 | 1996 | 3931 | 0.010 |
Why?
|
| Sleep | 1 | 2020 | 4820 | 0.010 |
Why?
|
| Aerosols | 1 | 2007 | 636 | 0.010 |
Why?
|
| Contraception Behavior | 1 | 2006 | 187 | 0.010 |
Why?
|
| Gadolinium DTPA | 1 | 2007 | 823 | 0.010 |
Why?
|
| Long-Term Care | 1 | 2008 | 631 | 0.010 |
Why?
|
| Hospitals, Teaching | 1 | 2009 | 1159 | 0.010 |
Why?
|
| Medical Records | 1 | 2009 | 1411 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2012 | 3629 | 0.010 |
Why?
|
| Hypoglycemia | 1 | 2011 | 895 | 0.010 |
Why?
|
| Prostatectomy | 1 | 2012 | 1841 | 0.010 |
Why?
|
| Virus Replication | 1 | 2011 | 2458 | 0.010 |
Why?
|
| Diet, Cariogenic | 1 | 2003 | 6 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 1999 | 2749 | 0.010 |
Why?
|
| International Classification of Diseases | 1 | 2009 | 936 | 0.010 |
Why?
|
| Korea | 1 | 2003 | 97 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2010 | 2635 | 0.010 |
Why?
|
| DMF Index | 1 | 2003 | 87 | 0.010 |
Why?
|
| Epidemiologic Methods | 2 | 1998 | 1328 | 0.010 |
Why?
|
| Carbonates | 1 | 2002 | 21 | 0.010 |
Why?
|
| Viral Proteins | 1 | 2010 | 1802 | 0.010 |
Why?
|
| Fee-for-Service Plans | 1 | 2008 | 714 | 0.010 |
Why?
|
| Vanadates | 1 | 2002 | 82 | 0.010 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 1995 | 2542 | 0.010 |
Why?
|
| Fuel Oils | 1 | 2002 | 36 | 0.010 |
Why?
|
| Hospitals, Pediatric | 1 | 2012 | 1876 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2011 | 6232 | 0.010 |
Why?
|
| Registries | 2 | 2010 | 8384 | 0.010 |
Why?
|
| Phonetics | 1 | 2004 | 204 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2013 | 6856 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2006 | 2298 | 0.010 |
Why?
|
| Radiography | 1 | 2013 | 6991 | 0.010 |
Why?
|
| Mitochondria | 1 | 1996 | 3682 | 0.010 |
Why?
|
| Ethanolamines | 1 | 2002 | 152 | 0.010 |
Why?
|
| Hippocampus | 1 | 2015 | 3782 | 0.010 |
Why?
|
| Hematologic Neoplasms | 1 | 2014 | 1907 | 0.010 |
Why?
|
| Medically Uninsured | 1 | 2007 | 841 | 0.010 |
Why?
|
| Bronchial Provocation Tests | 1 | 2001 | 216 | 0.010 |
Why?
|
| Students | 2 | 2005 | 1744 | 0.010 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2009 | 1006 | 0.010 |
Why?
|
| Observer Variation | 1 | 2007 | 2623 | 0.010 |
Why?
|
| Patient Care Team | 1 | 2012 | 2528 | 0.010 |
Why?
|
| Income | 1 | 2009 | 1879 | 0.010 |
Why?
|
| Accidents, Occupational | 1 | 2002 | 251 | 0.010 |
Why?
|
| Pneumonectomy | 1 | 2008 | 1159 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 6086 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2006 | 2280 | 0.010 |
Why?
|
| China | 1 | 2007 | 2395 | 0.010 |
Why?
|
| Phosphocreatine | 1 | 2001 | 261 | 0.010 |
Why?
|
| Cell Line | 2 | 2011 | 15604 | 0.010 |
Why?
|
| Surgical Procedures, Operative | 1 | 1992 | 1941 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2018 | 7460 | 0.010 |
Why?
|
| Cloning, Molecular | 2 | 1999 | 4168 | 0.010 |
Why?
|
| Apoptosis | 1 | 1996 | 9527 | 0.010 |
Why?
|
| Lymph Node Excision | 1 | 2006 | 1273 | 0.010 |
Why?
|
| Causality | 1 | 2007 | 1256 | 0.010 |
Why?
|
| Cell Survival | 1 | 2010 | 5793 | 0.010 |
Why?
|
| Osteoporosis | 1 | 2010 | 1606 | 0.010 |
Why?
|
| Brain Mapping | 1 | 2015 | 6739 | 0.010 |
Why?
|
| Phosphorus | 1 | 2001 | 336 | 0.010 |
Why?
|
| Clinical Protocols | 1 | 2006 | 1445 | 0.010 |
Why?
|
| Triage | 1 | 2007 | 997 | 0.010 |
Why?
|
| Radiotherapy Dosage | 1 | 2007 | 2921 | 0.010 |
Why?
|
| Age Distribution | 1 | 2006 | 2875 | 0.010 |
Why?
|
| Histones | 1 | 2010 | 2603 | 0.010 |
Why?
|
| Particle Size | 1 | 2004 | 1652 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2010 | 4179 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2010 | 5906 | 0.010 |
Why?
|
| Bone and Bones | 1 | 2010 | 2590 | 0.010 |
Why?
|
| Metals | 1 | 2004 | 713 | 0.010 |
Why?
|
| Thrombosis | 1 | 2013 | 2956 | 0.010 |
Why?
|
| Physical Exertion | 1 | 2002 | 668 | 0.010 |
Why?
|
| Antiviral Agents | 1 | 2011 | 3070 | 0.010 |
Why?
|
| Epidemiologic Studies | 1 | 2002 | 677 | 0.010 |
Why?
|
| Mental Disorders | 1 | 2019 | 6876 | 0.010 |
Why?
|
| Cardiac Volume | 1 | 1999 | 197 | 0.010 |
Why?
|
| Prostate | 1 | 2007 | 1781 | 0.010 |
Why?
|
| Potassium | 1 | 2002 | 1315 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2010 | 10765 | 0.010 |
Why?
|
| Antibodies, Viral | 1 | 2009 | 3215 | 0.010 |
Why?
|
| Emergency Medicine | 1 | 2007 | 1223 | 0.010 |
Why?
|
| Phosphates | 1 | 2001 | 765 | 0.010 |
Why?
|
| Electric Impedance | 1 | 2002 | 795 | 0.010 |
Why?
|
| Attitude of Health Personnel | 1 | 2011 | 3928 | 0.010 |
Why?
|
| HIV Long Terminal Repeat | 1 | 1997 | 86 | 0.010 |
Why?
|
| Defective Viruses | 1 | 1997 | 89 | 0.010 |
Why?
|
| Vulnerable Populations | 1 | 2003 | 718 | 0.010 |
Why?
|
| Disease | 1 | 2002 | 673 | 0.010 |
Why?
|
| Ribonucleosides | 1 | 1997 | 79 | 0.010 |
Why?
|
| Aminoimidazole Carboxamide | 1 | 1997 | 85 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2001 | 2488 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 1994 | 11932 | 0.010 |
Why?
|
| Synaptophysin | 1 | 1996 | 138 | 0.010 |
Why?
|
| DNA Fragmentation | 1 | 1996 | 240 | 0.010 |
Why?
|
| Monte Carlo Method | 1 | 2001 | 1262 | 0.010 |
Why?
|
| Body Height | 1 | 2002 | 1569 | 0.010 |
Why?
|
| Functional Residual Capacity | 1 | 1995 | 70 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1999 | 1990 | 0.010 |
Why?
|
| Arm | 1 | 1999 | 590 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 2001 | 2003 | 0.010 |
Why?
|
| Base Sequence | 2 | 1999 | 12430 | 0.010 |
Why?
|
| Creatine Kinase | 1 | 1997 | 684 | 0.010 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 1997 | 435 | 0.010 |
Why?
|
| Public Health | 2 | 1998 | 2680 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2010 | 19023 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2010 | 10486 | 0.010 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 1 | 1994 | 178 | 0.010 |
Why?
|
| Mice, Transgenic | 2 | 1997 | 9565 | 0.010 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 1994 | 183 | 0.010 |
Why?
|
| Medicaid | 1 | 2007 | 2843 | 0.010 |
Why?
|
| Atmosphere Exposure Chambers | 1 | 1993 | 51 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2010 | 17173 | 0.010 |
Why?
|
| Cadmium | 1 | 1994 | 217 | 0.010 |
Why?
|
| Bronchoscopes | 1 | 1993 | 64 | 0.010 |
Why?
|
| Echocardiography, Transesophageal | 1 | 1999 | 1096 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 1996 | 1435 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 1997 | 1904 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2011 | 22379 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 1994 | 1085 | 0.010 |
Why?
|
| Tidal Volume | 1 | 1995 | 518 | 0.010 |
Why?
|
| Hematocrit | 1 | 1994 | 623 | 0.010 |
Why?
|
| Particulate Matter | 1 | 2004 | 2615 | 0.010 |
Why?
|
| Nerve Degeneration | 1 | 1996 | 750 | 0.010 |
Why?
|
| Poly A | 1 | 1992 | 180 | 0.010 |
Why?
|
| Zidovudine | 1 | 1994 | 625 | 0.010 |
Why?
|
| Leukemia, Erythroblastic, Acute | 1 | 1992 | 176 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1999 | 6131 | 0.010 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 1993 | 761 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1992 | 1057 | 0.010 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1997 | 1493 | 0.010 |
Why?
|
| Zinc | 1 | 1994 | 677 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1992 | 1553 | 0.010 |
Why?
|
| Gene Deletion | 1 | 1997 | 2674 | 0.010 |
Why?
|
| Bronchi | 1 | 1993 | 850 | 0.010 |
Why?
|
| Drug Synergism | 1 | 1993 | 1762 | 0.010 |
Why?
|
| Gene Library | 1 | 1992 | 1062 | 0.010 |
Why?
|
| Random Allocation | 1 | 1993 | 2394 | 0.000 |
Why?
|
| Rabbits | 1 | 1994 | 4774 | 0.000 |
Why?
|
| Protein Conformation | 1 | 1996 | 3956 | 0.000 |
Why?
|
| Protein Kinases | 1 | 1994 | 1611 | 0.000 |
Why?
|
| Bronchoscopy | 1 | 1993 | 914 | 0.000 |
Why?
|
| DNA, Neoplasm | 1 | 1992 | 1748 | 0.000 |
Why?
|
| Residence Characteristics | 1 | 1996 | 2121 | 0.000 |
Why?
|
| Up-Regulation | 1 | 1994 | 4148 | 0.000 |
Why?
|
| Intraoperative Complications | 1 | 1992 | 1176 | 0.000 |
Why?
|
| Promoter Regions, Genetic | 1 | 1994 | 5801 | 0.000 |
Why?
|
| Cell Nucleus | 1 | 1992 | 2885 | 0.000 |
Why?
|
| RNA | 1 | 1992 | 2727 | 0.000 |
Why?
|
| RNA, Messenger | 1 | 1992 | 12806 | 0.000 |
Why?
|